A. T. Dinh-Xuan (Paris, France), P. Hassoun (Baltimore, United States of America)
Imatinib mesylate inhibited myofibroblasts proliferation of allergic granulomatous angiitis in murine model
H. Nagashima, N. Sasaki, K. Yamauchi, Y. Utsumi, N. Suzuki, S. Akiyama, Y. Nakamura, H. Kobayashi, H. Inoue, T. Sawai (Morioka, Japan)
|  |
Enhanced efficacy of combining imatinib with sildenafil in a rodent model of pulmonary arterial hypertension
N. Duggan, O. Bonneau, M. Hussey, D. Quinn, C. Walker, J. Westwick, M. Thomas (Horsham, United Kingdom; Boston, United States Of America)
| |
Effects of combination treatments with the PPAR β/δ agonist GW0742 and the phosphodiesterase type V inhibitor, sildenafil on markers of pulmonary hypertension in hypoxic rats
A. Reed, L. Bailey, H. Gashaw, L. Zhao, J. Wort, J. Mitchell (London, United Kingdom)
| |
NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats
F. Veit, M. Roth, B. Egemnazarov, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Bad Nauheim, Germany)
| |
Prevention of fetal programming of pulmonary vascular dysfunction by a histone deacetylase inhibitor
E. Rexhaj, U. Scherrer, C. Sartori (Lausanne-CHUV, Switzerland)
| |
A novel murine model of severe pulmonary arterial hypertension
L. Ciuclan, O. Bonneau, M. Hussey, N. Duggan, C. Walker, J. Westwick, M. Thomas (Horsham, United Kingdom)
|  |
Mice deficient in Raf kinase inhibitor protein (RKIP) have elevated indices of pulmonary hypertension
I. Morecroft, B. Doyle, M. MacLean (Glasgow, United Kingdom)
| |
Autoradiography of hypoxia tracer in the pulmonary hypertensive rat heart
Y. Y. Wong, I. Schalij, M. Verlaan, G. Ruiter, A. Vonk-Noordegraaf, A. Lammertsma, C. Molthoff, W. van der Laarse (Amsterdam, Netherlands)
| |
The combined use of L-arginine and tetrahydrobiopterin improves hemodynamic parameters in a rat model of pulmonary hypertension
C. Schreiber, A. Martischnig, M. Strobl, H. Bergmeister, I. Lang, D. Bonderman (Austria)
| |
Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
I. Polonio, M. Acencio, R. Pazetti, F. Almeida, C. Jardim, R. Souza (Brazil)
| |
Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model
V. Nikam, R. Schermuly, R. Dumitrascu, N. Weissmann, G. Kwapiszewska, W. Seeger, R. Voswinckel (Bad Nauheim, Giessen, Germany)
| |
Two rat models of hemolysis-induced pulmonary hypertension
V. Bilan, S. Tofovic (United States Of America)
| |
VIP prevents and reverses monocrotaline-induced PAH: Further protection by combination with bosentan
S. Hamidi, A. Szema, R. Khatami, S. Said (Northport, United States Of America)
| |
The hsp90 inhibitor, 17-AAG prevents and reverses the increases in lung calcineurin expression and activity associated with monocrotaline-induced right ventricular hypertrophy
J. Gallops, C. Dimitropoulou, S. Barman, J. Catravas (Augusta, United States Of America)
| |
Novel determinants of mechanical strain-induced endothelial cell apoptosis
R. Damico, B. Kim, H. Yadav, T. Simms, M. Damarla, P. Hassoun (Baltimore, United States Of America)
| |
Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension
A. Hameed, S. Francis, C. Newman, D. Crossman, A. Lawrie (Sheffield, United Kingdom)
| |
Vascular reverse remodeling in the mouse model of hypoxia-induced pulmonary hypertension
F. C. Weisel, G. Kwapiszewska, C. Kloepping, M. Roth, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Bad Nauheim, Germany)
| |
Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis
R. G. Marangoni, E. R. Parra, A. P. P. Velosa, W. R. Teodoro, N. H. Yoshinari, V. L. Capelozzi (Brazil)
| |
Bevacizumab administration in pulmonary arterial hypertension rat model decondary to chronical hypoxia exposure
C. Karaman, M. Karaman, E. S. Ucan, N. Gokmen, D. Gurel, C. Coker, Y. Adali, O. Yilmaz (Izmir, Turkey)
| |
Adenosine deaminase – adenosine pathway in hemolysis-induced pulmonary hypertension
S. Tofovic, V. Bilan, E. Jackson, O. Rafikova (Pittsburgh, United States Of America)
| |